CG Oncology, Inc.
CGON
$27.03
$1.616.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.24% | -8.35% | -55.83% | -7.95% | -11.62% |
| Total Depreciation and Amortization | 550.00% | -- | -100.00% | 200.00% | 75.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.73% | -24.97% | 487.02% | 562.17% | 66.42% |
| Change in Net Operating Assets | 1,747.12% | -90.42% | 43.92% | 13.21% | 135.79% |
| Cash from Operations | 4.50% | -41.69% | -29.79% | 1.25% | 38.03% |
| Capital Expenditure | 12.50% | 92.34% | -21,000.00% | 107.14% | -16.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.76% | -1,780.34% | -65.27% | 188.37% | 88.22% |
| Cash from Investing | 100.75% | -1,812.69% | -65.93% | 188.34% | 88.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -97.21% | -99.69% | 10,209.83% | 2,714.29% | -99.98% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -35.78% | -- | -- | 100.00% | 98.91% |
| Cash from Financing | -165.78% | -99.80% | 10,209.83% | 5,317.50% | -99.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 87.55% | -200.91% | 1,070.53% | 134.89% | -175.59% |